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Hasan H. Dosluoglu, MD,d Buffalo, NY; and South Bend, Ind
Objective: Endovascular repair (EVAR) has been increasingly used for ruptured abdominal aortic aneurysms (rAAAs),
especially in major academic centers. The goal of this article is to report our results with an EVAR-first approach for rAAA
which we adopted in 2001 in our community hospital.
Methods: All consecutive patients who underwent attempted repair for rAAA between February 2001 and July 2006 were
analyzed. Only patients with computed tomographic or visual verification of extraluminal blood were included.
Results: A total of 40 patients (30 men; mean age, 76.4  7.2 years; range, 57-89 years) presented with rAAA. Thirty
patients underwent attempted EVAR for rAAA, constituting 4.1% of all EVAR cases (n  738), and 10 patients had
attempted open repair. Twenty-one (53%) were transferred from another institution. Computed tomography was
performed in 97.5%. On arrival to the emergency department, 43%% were hypotensive (systolic blood pressure <80 mm
Hg). Transfemoral balloon occlusion was used in 12 cases (30%; 10 in the EVAR group and 2 in the open group). The
length of operation was 128 35 minutes (range, 77-210 minutes) in EVAR cases. EVAR was completed in 93.3% (iliac
anatomy and proximal endoleak caused open conversion in two cases). Out of the 10 open treated cases, 1 was converted
to EVAR and survived. The grafts used for EVAR were AneuRx (n  21), Zenith (n  5), and Ancure (n  4), and 97%
were bifurcated. Five patients (16.6%) in the EVAR group died within 30 days (four required balloon occlusion). The
mean length of stay was 9.1 6.2 days (range, 4-30 days) in survivors of EVAR. In the EVAR-treated group, two patients
died (7 and 9 months; unrelated), and six of the surviving patients (23%) required secondary procedures (five
femorofemoral bypasses for limb occlusions and one proximal cuff for a type I endoleak that caused repeat rupture)
during a mean follow-up of 13.8  10.4 months (range, 3-39 months). The mortality rate was 40% (4/10) in patients
who underwent open procedures during this period, with an overall mortality rate of 22.5% for all ruptures treated. The
difference in 30-day mortality in the EVAR and open groups did not reach statistical significance (17% vs 40%; P  .19).
In the entire cohort, hypotension (systolic blood pressure <80 mm Hg) on arrival and loss of consciousness were
associated with 30-day mortality. Balloon occlusion was correlated with mortality in the EVAR-treated group (44% vs
4%; P  .019). The multivariate analysis using logistic regression showed that hypotension (odds ratio [OR], 7.4; 95%
confidence interval [CI], 1.3-42.0; P .025), loss of consciousness (OR, 37.5; 95% CI, 3.4-40.8; P .003), and the need
for balloon occlusion (OR, 5.2; 95% CI, 1.8-25.5; P .042) were correlated with higher perioperative mortality, whereas
age greater than 76 years, coronary artery disease, chronic obstructive pulmonary disease, hypertension, diabetes, renal
insufficiency, and type of procedure did not.
Conclusions:Our results show that EVAR is feasible with favorable outcomes in patients presenting with rAAA in a busy
community hospital. There is a high secondary intervention rate, which can potentially be decreased by ensuring good
iliac limb anatomy at the end of the procedure and by a closer follow-up. (J Vasc Surg 2007;46:898-905.)Despite advances made in critical care, prehospital care,
anesthesia care, and postoperative techniques in recent
decades, themortality after open repair of ruptured abdom-
inal aortic aneurysms (rAAAs) remains 35% to 80%.1,2 This
has resulted in the use of the less invasive endovascular
aneurysm repair (EVAR)3,4 in an effort to improve survival
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898in these patients. Although some authors have reported
significantly decreased mortality (9%-45%) when compared
with historical controls,5-9 others have not shown any
significant differences between these two modalities.10,11
However, there is a wide variation between studies in the
distribution of unstable patients, inclusion of symptomatic
patients without rupture, exclusion criteria, and percentage
of patients treated by EVAR, thus making it extremely hard
to determine the true effect of EVAR on mortality after
rAAA.
In addition, most of the studies were reported from
either large academic centers4,5,12 or large referral centers
where regionalized medicine is practiced,9-11 and the effect
of EVAR on rAAA mortality in the community at large is
still largely unknown. We started using EVAR in elective
repair of AAAs in 1999 in our community hospital after
approval of the devices by the US Food and Drug Admin-
istration and developed a very high volume EVAR practice.
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rAAAs since our first EVAR of an rAAA in 2001. The goal
of this article is to report our management protocol, tech-
niques, and results with the EVAR-first approach in pa-
tients presenting with rAAA to our community hospital.
MATERIALS AND METHODS
All consecutive patients who presented with rAAA to
the Sisters of Charity Hospital between February 2001 and
October 2006 were included. Rupture was defined as visu-
alization of extraluminal blood by computed tomography
(CT), operative findings, or both. Patients with symptom-
atic AAA without CT evidence of extraluminal blood were
not included. Demographic characteristics, comorbidities,
clinical presentation, hemodynamic stability on arrival, pre-
operative serum creatinine, hemoglobin level, electrocar-
diographic findings of myocardial ischemia, transfer from
another institution, maximum aneurysm diameter (milli-
meters), operative time, type of stent graft used, intraoper-
ative events (including adjunctive use of intra-aortic bal-
loon placement), and 30-day postoperative outcomes and
follow-up (CT and clinical) were all obtained from patients’
hospital and office charts. Institutional review board ap-
proval was obtained for this retrospective study involving
chart review.
The diagnosis of rAAA in a stable patient was usually
made by the CT scan ordered by the emergency depart-
ment (ED) physician and read by an on-call radiologist.
The operating room team was activated by the ED physi-
cian, who would notify the vascular surgeon on call. We
have 24-hour coverage by a radiologist in our hospital. The
same would occur when a patient with a diagnosis of rAAA
was to be transferred to our ED. When an unstable patient
arrived in the ED with a suspected rAAA, the patient was
immediately transferred to the CT scanner as the operating
room was prepared for both EVAR and open repair. When
the vascular surgeons were in the hospital, they accompa-
nied the patient to the CT scanner and/or the operating
room. When they were not in the hospital, they would be
notified of the patient’s transfer to CT scanner or the
operating room, and the surgeon would see the patient
either in the CT scanner, en route to the operating room, or
in the operating room. The vascular surgeons would decide
the type of approach to use (open vs EVAR), as well as the
graft type to be used, with no further contact with the
radiologist. Two vascular surgeons were involved whenever
feasible; however, both vascular surgeons are equally capa-
ble and comfortable with both types of repair and operated
alone in 12 of the 40 cases in this cohort. One very unstable
patient with a known AAA who developed hypotension
while in the hospital was taken straight to the operating
room from the floor. This was the only patient who did not
have a preoperative CT scan. His rupture was verified with
the postprocedure CT scan, as was routinely obtained in all
patients after EVAR. The time of arrival to our ED and the
time of start of the operation were recorded, and the
intervals were calculated.Hemodynamic instability was defined as systolic blood
pressure less than 80 mmHg and/or loss of consciousness.
Blood pressure less than 80 mm Hg on arrival to the ED
was noted. If the patient became unstable at any time
before the operation, this was also noted. Permissive hypo-
tension was practiced and fluid resuscitation kept to a
minimum as long as the patient did not lose consciousness.
CT with intravenous contrast using 3-mm slices was per-
formed. Increased creatinine did not change the protocol
used, and all patients received intravenous contrast. Rup-
ture was defined when extravasated blood was seen outside
of the aneurysm sac either in the CT scan or in the operat-
ing room. The eligibility of EVAR vs open repair and the
type of graft to be used was determined by the surgeons,
both of whom have been reading CTs and performing
EVAR since 1999, using very similar criteria. The anatomic
inclusion criteria for EVAR included a neck length of at
least 5 mm, a neck diameter less than 28 mm (26 mm
before the 2003 approval of the Zenith [Cook Inc, Bloo-
mington, Ind] graft), and accessibility of the iliac arteries
(heavy calcification, tortuosity, and size 7 mm). Patients
with circumferential heavy calcification in the neck were
excluded, but tortuous necks were evaluated by intraoper-
ative angiogram for the feasibility of EVAR. Because of our
high volume of EVAR practice, we have always maintained
the most commonly used sizes of the commercially avail-
able endografts (Ancure [Guidant, St Paul, Minn], AneuRx
[Medtronic, Minneapolis, Minn], Excluder [Gore Inc,
Flagstaff, Ariz], and Zenith [Cook Inc, Bloomington,
Ind]) in our stock for treatment of rAAA with EVAR.
AneuRx grafts were used preferentially unless the neck
diameter was greater than 26mm, at which time the Zenith
graft was used. Bifurcated grafts were preferentially used.
Conversion to a uni-iliac graft was not necessary in any
patient. Before July 2003, one patient was treated with an
aortouni-iliac graft (Ancure) with contralateral common
iliac artery ligation and a femorofemoral bypass using a
ringed 8-mm polytetrafluoroethylene graft. If the patient’s
anatomy was not clear by the CT scan (patients who had
CT scans in an outside hospital with 5-mm cuts), if this
could not be performed, or if the patient was unstable, the
patient was taken straight to the operating room, and a
single femoral cutdown was performed with the patient
under local anesthesia. An aortogram was performed after
access to the aorta to evaluate the proximal neck for ade-
quacy of EVAR. In seven patients who did not seem to be
candidates for EVAR, EVAR was attempted. One of these
patients had persistent endoleak that led to immediate
conversion to open repair, and the second patient had a late
migration and rupture at 11 months and underwent suc-
cessful repair by using a cuff extension. If patient was not
deemed a candidate for EVAR, the femoral access was
maintained for possible use of balloon occlusion.
Dedicated vascular operating room personnel consist-
ing of a circulating nurse, scrub technician, and radiology
technician, in addition to the vascular surgeon (one or two)
experienced in both open repair and EVAR, were always
available. The roomwas prepared for open repair if needed.
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undergo regional anesthesia, all cases with rAAA were
performed under general anesthesia; however, local anes-
thesia was used in unstable patients for initial access, later to
be converted to general anesthesia when proximal control
was obtained. Similar to Mehta et al,12 we prefer general
anesthesia in these cases to expedite the process and to leave
open the possibility for open conversion. All procedures
were performed by vascular surgeons in the operating room
using the OEC 9800 system (GE Medical Systems, Salt
Lake City, Utah).
After the initial cutdown, usually performed simulta-
neously by two surgeons, a guidewire was advanced to the
descending thoracic aorta and was then changed to a su-
perstiff guidewire, over which a 16F sheath was placed into
the aorta. The balloon occluder (Reliant [Medtronic] or
Coda [Cook]) was made available and was placed through
this sheath at any time during the procedure if the patient
became more unstable with a worsening of hypotension or
lost consciousness. The contralateral femoral artery was
used to access the suprarenal aorta, and a marker flush
pigtail catheter was used to perform an angiogram. Heparin
was not used during these procedures, as is our routine in
rAAA cases, to decrease coagulopathy in a bleeding patient.
The stent graft deployment was completed as dictated by
each device in a routine fashion. We favored femoral access
in all patients who required balloon occlusion. We did not
find it necessary to use brachial access for balloon insertion
in any case in this series and prefer to support the balloon
via the sheath inserted via the femoral artery. After the
inflation of the balloon above the celiac artery, we delivered
the main body delivery device through the contralateral
sheath, and after we marked the renal arteries by using
retrograde injections through the sheath where the balloon
was inserted, the balloon was deflated, and the graft was
deployed. The balloon had to be reinserted and inflated in
the main body of the graft, below the renal arteries, in 8 of
the 10 cases in whom balloon occlusion was used. The
contralateral limb was cannulated, and iliac limb extensions
were deployed to complete the procedure. After comple-
tion of the graft deployment, the completion angiograms
were performed for type I or type III endoleaks, and no
patient left the operating room with these types of en-
doleaks. A CT scan with contrast was repeated before
discharge on all patients to exclude any endoleaks. We
would plan to treat type II endoleaks only if the patient
remained unstable. One stable patient with a type II en-
doleak was observed in our series.
Open repair was performed with the patient under
general anesthesia via the transabdominal approach in a
standard fashion with a Dacron graft (DuPont, Wilming-
ton, Del) in all cases, and supraceliac or infrarenal clamping
was used as deemed necessary. Cell-saving devices were
used only in patients who underwent open repair.
The measured outcomes included technical success
with complete sealing of the aneurysm, conversion, inten-
sive care unit (ICU) length of stay (LOS), total hospital
LOS, 30-day in-hospital mortality, complications, early andlate reinterventions, aneurysm-related events, and condi-
tion on last follow-up. The patients who underwent EVAR
were followed up with our follow-up protocol for elective
EVAR, which consisted of clinic visits and CT scans at 3, 6,
and 12 months and then yearly thereafter. The patients
who survived open repair were followed up yearly after
being seen within 1 month after discharge. These patients
did not have the vigorous post-EVAR surveillance with
repeated CT scans.
Data analysis was performed with SPSS 14.0 software
(SPSS Inc, Chicago, Ill). The descriptive statistics are given
as mean  SD, with median and range numbers indicated
in parentheses when data were skewed. Cross-tabulation of
predictive covariates was performed between two groups
(survivors vs nonsurvivors) by using the Fisher exact test for
nonparametric variables. Multivariate analysis was per-
formed with stepwise (forward: likelihood ratio) binary
logistic regression analysis for predicting perioperative
mortality (death within 30 days). Kaplan-Meier life tables
were used for statistical analysis of overall, reintervention-
free, and endoleak-free survival rates. All P values were
considered significant if .05.
RESULTS
A total of 40 patients (30 men; mean age, 76.4  7.2
years; range, 57-89 years) presented with rAAAs. Thirty
patients underwent attempted EVAR for rAAA, constitut-
ing 4.2% (n 738) of all EVAR cases and 75% (n 40) of
all patients who presented with rAAA during this period.
The patients’ demographic characteristics are shown in
Table I. The periprocedural characteristics are shown in
Table II. Twenty-one (53%) were transferred from another
institution. CT was performed in 39 (97.5%). The mean
time to the start of the operation from arrival to the EDwas
57  18 minutes (range, 19-98 minutes), and there was a
significant difference between stable and unstable patients
(65 17 minutes vs 49 15 minutes; P .02). The mean
size of the AAAwas 6.7 1.3 cm (range, 4.2-12.0 cm). On
arrival to the ED, 17 (43%) patients were hypotensive. Loss
of consciousness was seen in 6 (15%), and 21 (53%) became
unstable at some point before the operation. Transfemoral
Table I. Demographic characteristics of all patients
presenting with ruptured abdominal aortic aneurysms
(age, 76.4  7.2 years; range, 57-89 years)
Variable %
Male 75%
Coronary artery disease 63%
Hypertension 80%
Diabetes mellitus 20%
Cerebrovascular disease 8%
Hyperlipidemia 55%
Chronic pulmonary occlusive disease 43%
Renal insufficiency (creatinine 1.5 mg/dL) 25%
Cirrhosis 3%
Smokers (active) 35%balloon occlusion was used in 10 patients in the EVAR
blood
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were used in all patients but one. One patient who pre-
sented with a stable rupture and a marginal neck length (8
mm) was found to have a ruptured inflammatory aortic
aneurysm on exploration, and as a result of excessive diffi-
culty with exposure, he was successfully converted to
EVAR and survived. He remains problem free 24 months
after the procedure. AneuRx (n 22; 71%), Zenith (n 5;
16%), and Ancure (n  4; 13%) grafts were used (97%;
bifurcated).
The mean operation time was 126  32 minutes
(range, 77-210minutes) in the EVAR group and 192 27
minutes (range, 150-235 minutes) in open cases, all of
whom had bifurcated grafts placed. EVAR was completed
in 29 cases: 28 (93%) of EVAR-attempted cases and 1
conversion from the open group. Inability to deliver the
device because of iliac artery tortuosity and calcification
(one patient) and a proximal endoleak in another patient
with an 8-mm, 90° angled tortuous neck caused conversion
to open procedures in two patients (AneuRx was attempted
in both). Mean blood transfusion requirements were 2.6
2.7 units (range, 0-13 units; median, 2 units) in the EVAR
group and 5.0  1.9 units (range, 3-8 units; median, 4
units) in open cases (P  .008). The reasons for choosing
open repair were unfavorable neck anatomy in seven cases
and iliac anatomy in the remaining three cases. The clamp
could be placed infrarenally in three and suprarenally in six
cases, and the remaining patient with marginal neck anat-
omy was successfully converted to EVAR.
A total of 12 patients had common iliac aneurysms
larger than 2 cm in diameter. Two simply had extension of
the iliac limbs to external iliac arteries, and three had
additional coil embolizations of their internal iliac arteries
before placement of external iliac artery extensions. The
remaining common iliac aneurysms were sealed by using an
aortic extension cuff (24-28 mm). At least one internal iliac
artery was preserved in all patients.
Five patients (17%) in the EVAR group and four pa-
tients (40%) in the open group died within 30 days (P 
Table II. Periprocedural characteristics of patients who ha
abdominal aortic aneurysms
Variable EVAR
CT performed 97%
Transfer 57%
Unstable 50%
Initial systolic blood pressure 80 mm Hg 43%
Loss of consciousness 10%
Ischemic changes on ECG 13%
Need for aortic occlusion balloon 30%
Bifurcated device/graft 97%
Operation time (min)
Mean  SD 126  3
Range 77-210
Mean PRBCs transfused (units) 2.4  2
CT, Computed tomography; ECG, electrocardiogram; PRBCs, packed red.19). The 30-day mortality rate for the entire cohort was22.5%. In the EVAR group, one patient with oxygen-
dependent chronic obstructive pulmonary disease and cir-
rhosis with portal hypertension died 7 hours after the
procedure. Another patient who had a cardiopulmonary
arrest before the procedure had a persistent type I endoleak
from his severely angulated neck, which was recognized in
the operating room; additional placement of an aortic cuff
was not successful, and the procedure was immediately
converted to an open approach. Balloon occlusion was kept
until a suprarenal clamp could be placed and the repair
completed. Unfortunately, the patient died 8 hours later in
the ICU. The remaining three patients died of multiple
system organ failure within 48 hours after successful exclu-
sion of their aneurysms. They were all anuric and acidotic,
had increased liver function tests, and had acute respiratory
distress syndrome. In the open-treated group, four patients
died on postoperative days 1 (two patients), 5, and 8 from
multiple organ system failure. Three of these four patients
had suprarenal clamps placed, and all were unstable; two
lost consciousness before surgery.
The mortality rates in patients with various preopera-
tive and preoperative characteristics are shown in Table III
for all patients and for those treated with EVAR. Mortality
in patients who required balloon occlusion was 44% vs 4%
in those who did not (P  .019) in the EVAR group and
was 45% and 14%, respectively, in the entire cohort (P 
.083). The mortality rate was 5% in those who presented
and remained stable, whereas it was 38% in those who were
not stable (P .021). There was no difference in mortality
in those transferred from another institution (14%) as com-
pared with those presenting primarily to our ED (31%; P
.265). The stability rate was the same between transferred
patients (43%) and nontransferred patients (53%; P 
.752). Mortality was higher in those who experienced loss
of consciousness (83% vs 12%; P  .001) and ischemic
changes on the electrocardiogram (50% vs 16%; P .059).
The multivariate analysis using logistic regression showed
that hypotension on admission (systolic blood pressure
80 mm Hg; odds ratio [OR], 7.4; 95% confidence inter-
dovascular aneurysm repair (EVAR) for ruptured
Open P value Overall
100% .99 97.5%
40% .473 53%
60% .721 53%
40% .99 43%
30% .153 15%
40% .089 20%
20% .696 28%
100% NR NR
.001 NR
192  27
150-235
5.0  1.9 .008 NR
cells; NR, not relevant.d en
2
.7val [CI], 1.3-42.0; P  .025), loss of consciousness (OR,
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balloon occlusion (OR, 5.2; 95% CI, 1.8-25.5; P  .042)
were correlated with higher perioperative mortality,
whereas age older than 76 years, coronary artery disease,
chronic obstructive pulmonary disease, hypertension, dia-
betes, renal insufficiency, and type of procedure did not.
The perioperative mortality of unstable patients was 67%
(4/6) in the open group and 27% (4/15) in the EVAR-
treated group (P  .146).
The number of blood transfusions inversely correlated
with survival. All patients who required two units or less of
packed red blood cells in the EVAR group (n  21)
survived, whereas five (56%) died if more than two units
were used (P  .001). In addition, patients who required
three or four units of packed red blood cells but did not
require balloon occlusion survived, whereas those who
required balloon occlusion died. All three patients who
required more than four units of packed red blood cells
died.
The mean length of stay in the ICU was 3.2   1.4 days,
and the total hospital LOS was 9.4  6.4 days (range, 4-30
days) in surviving EVAR-treated patients. The major 30-
day morbidities in survivors included one (4%) myocardial
infarction, one (4%) deep vein thrombosis with pulmonary
embolism, and one (4%) limb ischemia secondary to graft
limb occlusion necessitating femorofemoral bypass. We did
not diagnose any abdominal compartment syndrome or
Table III. The effect of different factors on mortality
Variable
Perioperative
mortality
P valueYes No
Male 20% 30% .665
Age 76 y 29% 16% .457
Coronary artery disease 32% 7% .117
Hypertension 28% 0% .162
Diabetes mellitus 38% 19% .348
Cerebrovascular disease 0% 24% .99
Hyperlipidemia 23% 22% .99
Chronic pulmonary
occlusive disease 29% 17% .456
Renal insufficiency
(creatinine 1.5
mg/dL) 30% 20% .665
Cirrhosis 100% 21% .225
Smokers (active) 14% 27% .453
Transfer 14% 20% .265
Hypotension on arrival
(80 mm Hg) 41% 9% .023
Unstable before surgery 38% 5% .021
Loss of consciousness 83% 12% .001
Ischemia on ECG 50% 16% .059
Hardman score 1 35% 10% .127
Balloon occlusion 45% 14% .083
PRBCs 2 units 47% 0% .001
Type of repair (EVAR) 17% 40% .190
ECG, Electrocardiogram; PRBCs, packed red blood cells; EVAR, endovas-
cular aneurysm repair.bowel ischemia necessitating re-exploration in this group ofpatients. In the open group, two surviving patients had
postoperative pneumonia and renal insufficiency, and one
had limb ischemia necessitating thrombectomy. The mean
ICU and total hospital LOS were 4.7  2.0 days and 10 
3.7 days, respectively, in the open-treated patients who
survived (P  .046 for ICU stay; P  .149 for total LOS
when compared with EVAR cases).
The mean follow-up for the EVAR group was 13.8 
10.4 months (range, 3-48 months; median, 12 months
[16.0  11.2 months in survivors]). An additional four
patients presented with limb ischemia and underwent
femorofemoral bypass 4, 5, 7, and 7 months after the
EVAR, giving a total of five patients who underwent this
procedure (16%; 19% in those surviving 30 days). Only
one of these had an Ancure graft, and the rest had AneuRx
grafts placed. The overall late endoleak rate was 8%. The 6-
and 12-month endoleak-free survival rates were 96%  4%
(89%  8%) in survivors. One patient presented with a
repeat rupture 11 months after the first one, and the type I
endoleak caused by graft migration was successfully re-
paired with a proximal cuff extension; this patient remains
alive 5 months after the second repair. There was one type
II endoleak, which was managed conservatively and disap-
peared at the 6-month follow-up. Sac shrinkage of 5 mm or
more was observed in 62%, as measured by the surgeon in
the last CT, with only one sac increase noted in the patient
on CT when he presented with repeat rupture due to
proximal migration. This patient’s sac remained stable at
the last follow-up. The mean sac size on the last follow-up
CT was 5.6  1.0 cm, with a mean decrease of 1.0  0.9
cm. The overall aneurysm-related secondary reintervention
rate was 23% (6/26) in survivors. The 6- and 12-month
reintervention-free survival rates were 83% 8% and 67%
11%, respectively, in survivors.
The 12-month survival of the entire EVAR-treated
group was 77%  8% (91%  6% in those surviving the
initial operation). Late mortalities included two patients:
One patient with chronic steroid use and multiple medical
comorbidities died as a result of sepsis 7 months after a
perforated appendix, which fistulized into the aneurysm
sac. The second patient died 9months later from pancreatic
cancer.
DISCUSSION
There has been a significant increase in recent years of
reports involving EVAR in the treatment of rAAA.5-14 This
is likely the result of dissatisfaction on the surgeons’ part on
the lack of improvement on overall mortality with the
traditional open surgical repair. This increase in EVAR use
in rAAA also paralleled the dramatic increase in expertise
and availability of newer grafts in recent years. Although
earlier reports included only high-risk patients,3,4 more and
more centers are adopting an EVAR-first approach when-
ever feasible and are reporting improved outcomes with
decreased morbidity, mortality, blood transfusions, and
LOS.7,9,12,14 However, there is a wide variability between
studies, making comparisons and conclusions nearly impos-
sible regarding EVAR’s value in rAAAs. These variabilities
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stability, the minimum neck length criteria used for inclu-
sion for EVAR (5-15 mm), the willingness to proceed with
EVAR without preoperative CT scan in unstable patients,
the willingness to accept lower blood pressures before
rushing the patient to the OR, the availability of experi-
enced vascular surgeons, and the availability of grafts ac-
commodating more types of anatomy.3-14
We adopted the EVAR-first approach for rAAA after
acquiring a significant experience with elective EVAR after
its Food and Drug Administration approval in the United
States in 1999. After our first EVAR of rAAA, we adopted
this for all comers relatively easily because of the level of
familiarity our ED, OR, and radiology staff developed in
managing these patients as a result of our large volume of
EVARs in elective and urgent nonruptured aneurysms. We
emphasized (1) fluid restriction unless the patient lost
consciousness and (2) instant and simultaneous notification
of the vascular surgeon, OR, and CT scanner by the ED
staff in the event of an rAAA diagnosis or transfer. Although
we did not develop a protocol and performed test runs
before we started our EVAR experience in rAAA patients,
we do recommend this approach to centers that contem-
plate starting their own rAAA/EVAR program, especially if
their AAA volume is not high.
Because of its minimally invasive nature, EVAR should
intuitively have a bigger effect on patients with hemody-
namic instability; however, this is used as an exclusion
criterion in some studies11 or used as a criterion for skip-
ping the CT scanner, thus resulting in many fewer patients
receiving EVAR in this subgroup. Mehta et al12 reported
that only 3 of the 45 surgically treated patients who were
treated after they launched their EVAR for rAAA protocol
had absolutely prohibitive anatomy for EVAR. Reporting
on a mostly (65%) unstable group of patients, Moore et al9
reported a mortality rate of 5% after EVAR vs 28% in
surgically treated patients, with corresponding figures of
14% and 56% in hemodynamically unstable patients; this is
not too dissimilar to our 27% and 66% rates in unstable
patients. In contrast, Coppi et al6 reported 53% mortality
after EVAR, compared with 61% in the open group in
unstable rAAA patients. It is of note, however, that al-
though 52% of all patients were eligible, only 27% were
treated by EVAR in this series. Overall, 53% of our patients
were unstable before surgery (50% in the EVAR group and
60% in the open group). Hypotension on arrival to the ED,
loss of consciousness, and need for balloon occlusion, all of
which were related to instability, were correlated with
poorer outcomes, and the type of treatment did not seem to
affect perioperative survival, likely because of the small
number of patients treated. Although our mortality was
significantly higher in unstable than in stable patients (38%
vs 5%; P  .021), it is still reasonably low, especially when
one considers that the study included all comers and that
hemodynamic instability was not an exclusion criterion.
Successful exclusion of rAAAwith EVARwas accomplished
in 72.5% of all patients with rAAA, including the two
conversions: one for iliac anatomy and the other for persis-tent proximal endoleak. Incidentally, this seems to be very
high when compared with other studies that include all
comers (18%-49%).6,7,10-12 Our number is also almost
double the previously quoted 40% of EVAR suitability for
all comers with rAAA.16 However, the criteria used in those
studies for anatomic suitability, including neck length and
quality, were very stringent, and our willingness to com-
plete the procedure even in those with unclear neck anat-
omy by CT scan may have contributed to this high percent-
age. We think that sealing the rAAA even when the
anatomic features are not ideal and converting a life-threat-
ening situation into a more manageable and stable condi-
tion is an acceptable short-term goal, especially in this
high-risk patient population.
The CT scan is usually skipped in those with blood
pressures less than 80 mm Hg in most protocols, with the
fear of losing the patient en route; however, this is rarely the
cause of patient death as long as fluid restriction is followed
and unnecessary delays are avoided between the ED, CT
scanner, and OR, especially when the speed of the modern
CT scanners and mandatory times for OR setup are consid-
ered. Lloyd et al17 reported the time to death from admis-
sion to be more than 2 hours in nonoperated rAAA pa-
tients, with the median time being 10.5 hours from
admission to the ED, which should give ample time for
both CT scan and OR preparation for most patients. Our
CT scan acquisition rate of 97.5% is one of the highest in
the literature reporting on all comers with rAAA, and the
mean time from arrival to the ED and start of the operation
(49 minutes) in unstable patients is acceptable.
There is no 24-7 in-house coverage by vascular sur-
geons in our hospital, and there are no surgery residents or
vascular surgery fellows taking the first call from the ED, as
is reported from the large academic centers.9,10,12 We have
not found this to be a problem because of the simultaneous
activation of all vascular surgeons, CT scanner, andOR staff
by the ED physicians, mostly even before the patient with a
high likelihood of rAAA reaches the hospital. Those trans-
ferring from other institutions would be accompanied by
their CT results, thus making it even easier to make plans
ahead of time, but there was never a time that surgery was
delayed because of surgeon’s late arrival. It is important to
note that the surgeons live within 20 to 25 minutes of
driving distance from the hospital, and the entire surgical
team would have been mobilized before the surgeons’
arrival.
Although balloon occlusion was initially described via
the transbrachial approach with a cutdown, the transfemo-
ral approach has been our preferred approach, as is the case
for most surgeons.15 This maneuver was necessary in a third
of our patients but was necessary in up to 73% of patients in
some series.14 Because of its inherent potential complica-
tions, such as mesenteric or renal artery ischemia, with
additional risks of embolization or thrombosis, it is very
important not to use balloon occlusion unless it is abso-
lutely necessary. We did not encounter any complications
related directly to balloon occlusion in this series involving
12 patients, and the 45% mortality in this group was a
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Uni-iliac grafts have been suggested as a means of
expediting exclusion of AAA by some authors6,10; how-
ever, we have not found placement of bifurcated grafts to
be an issue during surgery. Still, we would not hesitate to
convert to an aortouni-iliac configuration, followed by
contralateral occlusion and femorofemoral bypass, if con-
tinued excessive bleeding coupled with difficult contralat-
eral cannulation were encountered. We have encountered
additional limb occlusions (19% in survivors) in our pa-
tients, all of whom were treated with femorofemoral bypass
grafts. This constituted the most common reason for
aneurysm-related secondary intervention in our series. We
think that this was the result of not performing the oblique
views of the iliac arteries at the end of the procedure in these
emergency cases, as is our routine in elective cases. Avoid-
ance of contrast load and the tendency to end the emer-
gency operation as soon as possible may have been the
reasons for this practice, but we have since been paying
more attention to the quality of the iliac arteries and graft
limbs at the completion of the EVAR in these patients. Our
limb occlusion rate in the elective EVAR population is
2.7%, and we think that the higher rate in rAAA patients
resulted from failing to recognize the anatomic defects in
the final repair.
The secondary intervention rate following emergency
EVAR has been reported to be very similar to that following
elective EVAR by Oranen et al,18 with a 2-year intervention
rate of 16%, whereas Hechelhammer et al13 reported this to
be much higher, at 35%. Endoleaks with or without migra-
tion were the most common causes for reintervention in
these series, whereas we had only one late type I endoleak
due to migration with rupture in our series. One patient
with type II endoleak was treated conservatively; type II
endoleaks have not been reported to cause problems after
rAAA treatment with EVAR.19
We have not diagnosed any abdominal compartment
syndrome, which has been reported in up to 18% of patients
after EVAR for rAAA,12 in our series. However, we have
not routinely performed bladder pressure measurements.
We rely on other criteria (tense distended abdomen, in-
creased airway pressures, hypotension, and oligoanuria).
We have recently adopted routine bladder pressure mea-
surements. Mehta et al12 suggested that they started seeing
less abdominal compartment syndrome after they stopped
using heparin in their patients. We have not used heparin in
rAAA patients from the beginning of our experience, and it
is possible that this may have affected our favorable experi-
ence with this particular complication.
There are some weaknesses of our study. It is retrospec-
tive, and data were not prospectively collected. We have not
analyzed the outcome of patients treated before the EVAR-
first approach was started, thus making it hard to prove that
we improved the mortality in patients with rAAA in our
hospital, although comparing results with historical con-
trols has its own drawbacks. Because the duration encom-
passes nearly 4 years, there has been a significant variation inthe availability of the types of stent grafts; therefore, our
current experience is likely not represented uniformly by
the study group. Finally, the lack of a written protocol may
have caused some variations in the way some patients were
treated, especially before reaching the OR. However, we do
not believe that such small variations were significant
enough to have any effect on the final outcome of any
patient in this series.
CONCLUSIONS
Our results, along with the results of other studies,
show that EVAR is feasible, with favorable outcomes in
patients presenting with rAAA in a busy community hospi-
tal, as long as there are trained personnel who are capable of
performing open or EVAR procedures in rAAA. This
should be performed in the OR so the patient can undergo
emergency conversion if necessary. The perioperative mor-
tality is still largely determined by the patient’s hemody-
namic status at presentation. The relatively high reinterven-
tion rate can be potentially decreased by ensuring good iliac
anatomy at the end of the procedure, and close follow-up is
necessary to ensure early diagnosis of late-onset endoleaks
to prevent secondary ruptures.
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